These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9692356)

  • 1. Treatment of human immunodeficiency virus (HIV)-associated nephropathy.
    Kimmel PL; Bosch JP; Vassalotti JA
    Semin Nephrol; 1998 Jul; 18(4):446-58. PubMed ID: 9692356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
    Gozdowska J; Durlik M
    Przegl Lek; 2008; 65(2):82-6. PubMed ID: 18663906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study.
    Khanna R; Tachopoulou OA; Fein PA; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2005; 21():159-63. PubMed ID: 16686310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated nephropathy.
    Khan S; Haragsim L; Laszik ZG
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):307-13. PubMed ID: 16815235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of HIV-infected patients with ESRD.
    Novak JE; Szczech LA
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):102-10. PubMed ID: 20005494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance hemodialysis in patients with HIV-associated nephropathy.
    Dave MB; Shabih K; Blum S
    Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-associated nephropathy.
    Rajvanshi P; Gupta B
    J Assoc Physicians India; 2001 Aug; 49():813-8. PubMed ID: 11837470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment.
    Herman ES; Klotman PE
    Semin Nephrol; 2003 Mar; 23(2):200-8. PubMed ID: 12704580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated nephropathy: clinical characteristics and therapeutic options.
    Bologna RM
    AIDS Read; 1999; 9(1):38-42. PubMed ID: 12728882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of HIV infection in dialysis patients: results of a national multicenter study].
    Poignet JL; Desassis JF; Chanton N; Litchinko MB; Zins B; Kolko A; Patte R; Sobel A
    Nephrologie; 1999; 20(3):159-63. PubMed ID: 10418006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Options for renal replacement therapy: special considerations.
    Becker BN; Stone WJ
    Semin Nephrol; 1997 May; 17(3):176-87. PubMed ID: 9165647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-1 associated nephropathy (HIVAN): epidemiology, pathogenesis, histology, diagnosis, and medical management.
    Lochner ML; Wolf A
    Nephrol Nurs J; 2006; 33(3):259-67; quiz 268-9. PubMed ID: 16859198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of rationing dialysis therapy in biopsy-proven end-stage renal disease in South Africa.
    Okpechi IG; Swanepoel CR; Rayner BL
    J Nephrol; 2012; 25(4):551-7. PubMed ID: 21956769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy in the treatment of HIV-associated nephropathy.
    Atta MG; Gallant JE; Rahman MH; Nagajothi N; Racusen LC; Scheel PJ; Fine DM
    Nephrol Dial Transplant; 2006 Oct; 21(10):2809-13. PubMed ID: 16864598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV-related nephropathy: epidemiologic and therapeutic aspects].
    Martinez F
    Nephrologie; 2001; 22(6):299-300. PubMed ID: 11715606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.